CSBR:NASDAQ
Champions Oncology Inc
USD 4,59
arrow_downward
-1,89%(-0,088) 1D
17 Nov., 16:00:00 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,91 m
Avg. vol.
7,80 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
Open
USD 4,70
High
USD 4,70
Low
USD 4,59
Mkt. cap
63,91 m
Avg. vol.
7,80 k
Volume
0,00
52-wk high
USD 8,31
52-wk low
USD 4,52
EPS
-USD 0,08
Beta
0,47
Shares outstanding
13,92 m
No. of employees
217
News stories
From web sources and news partners
Benzinga
·
54 minute gelede
Stock Market: Will S&P 500 Open Up or Down Today?
Latest news from Azerbaijan
·
29 minute gelede
Dow, S&P 500, Nasdaq futures extend losses for fourth session amid AI sell-off
BigGo Finance
·
9 uur gelede
Wall Street Split on 2027 S&P 500 Outlook: Wells Fargo's 8,200 vs. Morgan Stanley's 8,700
Traders Union
·
6 uur gelede
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com